We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Precision Tracking of Samples Enabled at Low Temperatures

By LabMedica International staff writers
Posted on 28 Feb 2012
A new solution enables real-time (RT) precision tracking of samples in situ at low temperatures.

Difficulties in tracking samples are due to the inability to locate automatically the samples, as well as a lack of robust connection between the physical sample and archiving software. More...
The task is further complicated at ultra low temperatures.

The ColdTrack platform was designed to solve these problems. The platform enables electronic tracking by associating a unique electronic tag with each sample, enabling fast mapping of sample boxes.
Tens of millions of new biological samples are collected and stored annually by pharmaceutic companies, universities, hospitals, diagnostic testing and research centers, national genetic databases, and forensic laboratories.

BioTillion (Skillman, NJ, USA), a privately held company, introduced the ColdTrack platform at the SLAS 2012 meeting in San Diego (CA, USA), which was held in February 2012.

Each ColdTrack sample vial has unique radio frequency identification (RFID) tag that cannot be changed or replicated in another, and contains user-defined data that may be modified by a user. The RFID-tagged vials survive exposure to a wide range of temperatures: from liquid nitrogen temperatures (-196 °C) up to the maximum operating temperature of the vial (121 °C) without loss of data or functionality.

A freezer box is mapped by placing the box containing one or more ColdTrack vials on a BoxMapper. The BoxMapper can map the contents of an 81-sample freezer box in about a second. The reader is connected to a computer using a USB cable.

The BoxMapper is integrated with a group of laboratory information-management systems (LIMS) packages. The details of the CDR-LIMS interaction is slightly different for each LIMS package but in all cases the box contents are transferred to the LIMS program automatically so that the user does not need to enter vial IDs or box locations.

Related Links:
BioTillion
SLAS 2012 meeting


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
New
Automated Immunoassay Analyzer
SuperFlex™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes

Secondary prevention after myocardial infarction or stroke relies on antiplatelet therapy, yet responses vary widely and both recurrent thrombosis and bleeding remain persistent risks. In the United Kingdom,... Read more

Molecular Diagnostics

view channel
Image: Signatera uses ctDNA analysis to identify residual tumor-derived genetic material after definitive treatment (image credit: Adobe Stock)

Blood-Based MRD Test Predicts Recurrence Risk After Lung Cancer Surgery

Assessing recurrence risk after surgery for early-stage non-small cell lung cancer remains challenging, complicating adjuvant therapy and surveillance decisions. Blood-based molecular residual disease... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Type 1 diabetes affects more than 9 million people worldwide and can begin years before symptoms appear, making early identification of at-risk children difficult (Image Credit: iStock)

Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

Type 1 diabetes (T1D) affects more than 9 million people worldwide, including 1.8 million children and adolescents, and often begins years before symptoms appear. Early identification of children who are... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.